23
May

After a manufacturing issue spiked its pitch for FDA approval, a new diabetes drug from Eli Lilly and Boehringer Ingelheim has secured European clearance, lining up to compete in a crowded market.

…read more

Source: Lilly, Boehringer pick up EU nod for FDA-spurned diabetes treatment

    

0 No comments